Overview

Study Evaluating the Bioavailability of Miricorilant With Optional Food Effect Assessment in Healthy Adult Subjects

Status:
ACTIVE_NOT_RECRUITING
Trial end date:
2025-12-13
Target enrollment:
Participant gender:
Summary
This single-center, randomized, open-label study will assess the relative bioavailability of 2 miricorilant (CORT118335) tablet formulations.
Phase:
PHASE1
Details
Lead Sponsor:
Corcept Therapeutics
Treatments:
CORT118335